Protein could be marker of early ovarian cancer. (Blood test).
Dr. Bin Ye reported a case-control study of 99 patients with ovarian cancer and 201 age-matched controls at the annual meeting of the American Association for Cancer Research. The hemoglobin-binding protein haptoglobin-[alpha] was elevated in the sera of women with all histologic types of ovarian cancer.
Further analysis showed that the protein identified ovarian cancer with 82% sensitivity and 83% specificity, said Dr. Ye, a research fellow at Harvard Medical School, Boston.
Dr. Ye and colleagues used liquid chromatography mass spectroscopy, and the Surface-Enhanced Laser Desorption/Ionization (SELDI) ProteinChip system, a technique developed by Ciphergen Biosystems of Fremont, Calif. The system permits the rapid analysis of hundreds of proteins to create a "snapshot" of the protein activity in a patient's tumor.
Through this analysis, "we found that the [alpha] subunit of the haptoglobin protein was elevated in serum samples across patients with different subtypes of ovarian tumors, and less so across the healthy control samples." Mean haptoglobin-[alpha] levels were 74 [micro]g/mL in serum from the cancer patients, compared with 41 [micro]g/mL from the control subjects, Dr. Ye said.
|Printer friendly Cite/link Email Feedback|
|Publication:||OB GYN News|
|Date:||Sep 1, 2002|
|Previous Article:||Anastrozole effective for newly diagnosed breast cancer. (Adjunctive treatment).|
|Next Article:||PMDD treatment may require fine tuning. (Selective serotonin reuptake inhibitors).|